Product Information
CLARAVIS 10 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.8768 per EA under NDC 00555105486. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Apr 11, 2003. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555105486
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ISOTRETINOINApproval Type
Generic (ANDA)
FDA Application
ANDA076356FDA Approved
4/11/2003
TE Code
AB1
On Market Since
5/9/2003
Pharmacological Classes
Price Statistics
The NADAC for CLARAVIS 10 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 72.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8768 per EA |
|---|---|
| All-time high | $7.2608 (Mar 11, 2015) |
| All-time low | $1.3264 (Aug 21, 2024) |
| 52-week high | $2.2921 |
| 52-week low | $1.6125 |
| Median price | $3.0358 |
| Average price | $3.7867 |
| Largest weekly change | -40.2% (Mar 22, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLARAVIS 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLARAVIS 10 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $1.8768 per EA (NDC 00555105486), effective Aug 19, 2026.
How has the price of CLARAVIS 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLARAVIS 10 MG CAPSULE has declined 72.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLARAVIS 10 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CLARAVIS 10 MG CAPSULE has ranged from a low of $1.3264 (Aug 21, 2024) to a high of $7.2608 (Mar 11, 2015), with a median of $3.0358 per EA.
Are there cheaper alternatives to CLARAVIS 10 MG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLARAVIS 10 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CLARAVIS 10 MG CAPSULE?
CLARAVIS 10 MG CAPSULE (NDC 00555105486) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.